Fundz

Fundz Deep Dive

Everything you need to win Fady Boctor — in one platform.

Who to reach, what to say, and why now on Fady Boctor — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Fady Boctor — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Petros Pharmaceuticals Announces Share Grants To Executive Team

PUBLIC · PTPIJun 05, 2026•10 days ago

Position

Chief Commercial Officer

Company

Petros Pharmaceuticals, Inc.

Fady Boctor
New YorkBiotechnologyHealthcareHealth CareMen's

Description

On June 5, 2026, Petros Pharmaceuticals approved significant grants of restricted shares to key executives and directors. The grants, which total 7 million shares, are intended to incentivize leadership and align their interests with shareholders. Each recipient received a specific allocation of shares as part of the RSA Awards

Company Information

Company

Petros Pharmaceuticals, Inc.

Location

1185 AVENUE OF THE AMERICAS, SUITE 249

New York, United States

About

Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Petros Pharmaceuticals, Inc.'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.